title: The Incidence of Blindness Due to Idiopathic Intracranial Hypertension in the UK.
abstract: OBJECTIVE
  To determine the incidence of blindness secondary to idiopathic intracranial hypertension (IIH) in the United Kingdom.
  
  
  METHODS
  New cases of blindness occurring secondary to IIH were identified prospectively through the British Ophthalmological Surveillance Unit (BOSU) from October 2005 to November 2006. Only idiopathic cases of intracranial hypertension and those meeting the World Health Organisation`s definition of blindness were included. Cases that were already blind or had already been blind registered before the study period were excluded.
  
  
  RESULTS
  There were 24 new cases of registerable blindness secondary to IIH reported during the 12 month period. Questionnaires were completed for 19 cases. Of these 19 cases, 3 were not truly idiopathic and 3 cases did not fulfil the strict criteria for blindness. One case was a duplicate report. There were 12 definite cases of blindness secondary to IIH giving a UK incidence of blindness secondary to IIH of 0.6-2% (assuming a UK population of 63.2 million and an incidence of IIH of 1-3/100,000). If the 5 cases reported as blind but without a completed questionnaire are assumed to be true cases then the incidence of blindness would be 1-3%.
  
  
  CONCLUSIONS
  The results of this study suggest that approximately 1-2% of new cases of IIH are likely to become blind in a given year. This contrasts with rates of between 4-10% reported previously in hospital-based studies, but may be a more accurate figure for the population as a whole. Under-ascertainment and improving standards of care may also have contributed to the lower figure than previously reported.
authors.affiliation: Royal Hospitals Belfast Health and Social Care Trust, Ireland.
authors.forename: Jl
authors.initials: J
authors.lastname: Best
authors.forename: G
authors.initials: G
authors.lastname: Silvestri
authors.forename: Bj
authors.initials: B
authors.lastname: Burton
authors.forename: B
authors.initials: B
authors.lastname: Foot
authors.forename: J
authors.initials: J
authors.lastname: Acheson
keywords: Blindness; intracranial hypertension; pseudotumour cerebri.
references.citation: Arch Neurol. 1982 Aug;39(8):461-74
references.pmid: 7103794
references.citation: Neurology. 1991 Feb;41(2 ( Pt 1)):239-44
references.pmid: 1992368
references.citation: Lancet. 2011 Aug 27;378(9793):838-47
references.pmid: 21872752
references.citation: Arch Neurol. 1990 Mar;47(3):315-20
references.pmid: 2310315
references.citation: Am J Public Health. 1983 Jul;73(7):795-7
references.pmid: 6859365
references.citation: Eye (Lond). 2003 Jan;17(1):9-15
references.pmid: 12579163
references.citation: Eye (Lond). 1998;12 ( Pt 1):111-8
references.pmid: 9614526
references.citation: Eye (Lond). 1993;7 ( Pt 1):172-9
references.pmid: 8325412
references.citation: Brain. 1991 Feb;114 ( Pt 1A):155-80
references.pmid: 1998880
references.citation: Am J Prev Med. 1986 Nov-Dec;2(6):345-50
references.pmid: 3453201
references.citation: Neurosurgery. 2005 Jul;57(1):97-108; discussion 97-108
references.pmid: 15987545
references.citation: Ophthalmology. 1984 Nov;91(11):1303-12
references.pmid: 6514295
references.citation: Arch Neurol. 1993 Jan;50(1):78-80
references.pmid: 8418804
references.citation: Surv Ophthalmol. 2007 Nov-Dec;52(6):597-617
references.pmid: 18029269
references.citation: Ophthalmology. 2009 Sep;116(9):1808-1813.e1
references.pmid: 19643491
references.citation: J Neurol Sci. 1993 May;116(1):18-28
references.pmid: 8509801
references.citation: Arch Neurol. 1988 Aug;45(8):875-7
references.pmid: 3395261
references.citation: Eur J Neurol. 2011 Oct;18(10):1266-8
references.pmid: 21426442